These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 29255622)

  • 1. Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression.
    Nallagangula KS; Nagaraj SK; Venkataswamy L; Chandrappa M
    Future Sci OA; 2018 Jan; 4(1):FSO250. PubMed ID: 29255622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver fibrosis markers in alcoholic liver disease.
    Chrostek L; Panasiuk A
    World J Gastroenterol; 2014 Jul; 20(25):8018-23. PubMed ID: 25009372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.
    Sebastiani G; Alberti A
    World J Gastroenterol; 2006 Jun; 12(23):3682-94. PubMed ID: 16773685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive diagnosis of advanced fibrosis and cirrhosis.
    Sharma S; Khalili K; Nguyen GC
    World J Gastroenterol; 2014 Dec; 20(45):16820-30. PubMed ID: 25492996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the clinical use of collagen as biomarker of liver fibrosis.
    Meurer SK; Karsdal MA; Weiskirchen R
    Expert Rev Mol Diagn; 2020 Sep; 20(9):947-969. PubMed ID: 32865433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic acid as a non-invasive biomarker of liver fibrosis.
    Neuman MG; Cohen LB; Nanau RM
    Clin Biochem; 2016 Feb; 49(3):302-15. PubMed ID: 26188920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects in non-invasive assessment of liver fibrosis: Liquid biopsy as the future gold standard?
    Lambrecht J; Verhulst S; Mannaerts I; Reynaert H; van Grunsven LA
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1024-1036. PubMed ID: 29329986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive assessment of liver fibrosis: key messages for clinicians.
    Caviglia GP; Touscoz GA; Smedile A; Pellicano R
    Pol Arch Med Wewn; 2014; 124(6):329-35. PubMed ID: 24781707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive biochemical markers of liver fibrosis.
    Grigorescu M
    J Gastrointestin Liver Dis; 2006 Jun; 15(2):149-59. PubMed ID: 16802010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease.
    Pavlov CS; Casazza G; Nikolova D; Tsochatzis E; Burroughs AK; Ivashkin VT; Gluud C
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010542. PubMed ID: 25612182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study.
    Vali Y; Lee J; Boursier J; Petta S; Wonders K; Tiniakos D; Bedossa P; Geier A; Francque S; Allison M; Papatheodoridis G; Cortez-Pinto H; Pais R; Dufour JF; Leeming DJ; Harrison SA; Chen Y; Cobbold JF; Pavlides M; Holleboom AG; Yki-Jarvinen H; Crespo J; Karsdal M; Ostroff R; Zafarmand MH; Torstenson R; Duffin K; Yunis C; Brass C; Ekstedt M; Aithal GP; Schattenberg JM; Bugianesi E; Romero-Gomez M; Ratziu V; Anstee QM; Bossuyt PM;
    Lancet Gastroenterol Hepatol; 2023 Aug; 8(8):714-725. PubMed ID: 36958367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Validation Study of Non-invasive Scoring Systems for Assessing Severity of Hepatic Fibrosis in a Cohort of South Indian Patients With Non-alcoholic Fatty Liver Disease.
    Mathew JF; Panackel C; Jacob M; Ramesh G; John N
    J Clin Exp Hepatol; 2024; 14(5):101407. PubMed ID: 38699513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of diagnostic techniques of hepatic fibrosis.
    Hassan S; Syed S; Kehar SI
    J Pak Med Assoc; 2014 Aug; 64(8):941-5. PubMed ID: 25252523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation.
    Crossan C; Tsochatzis EA; Longworth L; Gurusamy K; Davidson B; Rodríguez-Perálvarez M; Mantzoukis K; O'Brien J; Thalassinos E; Papastergiou V; Burroughs A
    Health Technol Assess; 2015 Jan; 19(9):1-409, v-vi. PubMed ID: 25633908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum markers of liver fibrosis: combining the BIPED classification and the neo-epitope approach in the development of new biomarkers.
    Veidal SS; Bay-Jensen AC; Tougas G; Karsdal MA; Vainer B
    Dis Markers; 2010; 28(1):15-28. PubMed ID: 20164543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis.
    Zehra M; Curry JC; Pillai SS; Lakhani HV; Edwards CE; Sodhi K
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive fibrosis seromarkers as a predictor of liver fibrosis in chronic hepatitis C and/or non-alcoholic steatohepatitis.
    Ahmed L; Salama H; Ahmed R; Hamdy S; Al-Akel W; Shafi SA; Mahgoub A; Hareedy A; Fathy W
    Arab J Gastroenterol; 2009 Mar; 10(1):14-20. PubMed ID: 24842131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease.
    Boyle M; Tiniakos D; Schattenberg JM; Ratziu V; Bugianessi E; Petta S; Oliveira CP; Govaere O; Younes R; McPherson S; Bedossa P; Nielsen MJ; Karsdal M; Leeming D; Kendrick S; Anstee QM
    JHEP Rep; 2019 Sep; 1(3):188-198. PubMed ID: 32039369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New diagnostic method for liver fibrosis and cirrhosis.
    Han KH; Yoon KT
    Intervirology; 2008; 51 Suppl 1():11-6. PubMed ID: 18544943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation.
    Stevenson M; Lloyd-Jones M; Morgan MY; Wong R
    Health Technol Assess; 2012; 16(4):1-174. PubMed ID: 22333291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.